紫杉醇纳米粒-微球系统的研制
发布时间:2018-10-08 15:01
【摘要】:目的制备紫杉醇纳米粒-微球系统(taxol nanoparticals-in-microsphere system,TAX-NiMS),并考察其体外释放特性。方法以聚乳酸-羟基乙酸共聚物(poly(lactic-co-glycolic acid),PLGA)为载体,采用乳化溶剂挥发法制备紫杉醇纳米粒(taxol nanoparticals,TAX-NPs)。以包封率、载药量及粒径为考察指标,采用单因素试验法优化处方。采用内源乳化凝胶法,以海藻酸钙为包裹材料,制备包覆TAX-NPs的微球系统。在扫描电镜和透射电镜下观察TAX-NiMS的表面和内部形态,并测定其粒径及体外释放特性。结果纳米粒优化处方:PLGA质量浓度为100 g·L-1,聚乙烯醇质量浓度为10 g·L-1,油相与水相体积比为1∶10,超声功率为300 W。微球优化处方:海藻酸钠(NaALG)质量浓度为15 g·L-1,Span-80质量浓度为10 g·L-1,Ca CO3与Na ALG质量比为1∶3,油相与水相体积比为1∶5。此条件下制备的TAX-NiMS的包封率、载药量和平均粒径分别为(84.33±1.11)%、(1.12±0.15)%和(2.678±0.014)μm。TAX-NiMS的12h释放量仅达到16.51%。结论 TAX-NiMS的制备方法稳定可控,且突释效应显著减小,为药物新剂型的开发提供了思路。
[Abstract]:Objective to prepare paclitaxel nanoparticles-microspheres system (taxol nanoparticals-in-microsphere system,TAX-NiMS) and investigate its release characteristics in vitro. Methods the paclitaxel nanoparticles (taxol nanoparticals,TAX-NPs) were prepared by emulsifying solvent volatilization with polylactic acid-glycolic acid copolymer (poly (lactic-co-glycolic acid) as the carrier. The encapsulation efficiency, drug loading and particle size were used to optimize the formulation. The microspheres coated with TAX-NPs were prepared using calcium alginate as encapsulation material by internal emulsifying gel method. The surface and internal morphology of TAX-NiMS were observed by SEM and TEM, and its particle size and release characteristics in vitro were measured. Results the optimized formulation was 100 g / L ~ (-1), 10 g / L ~ (-1) of polyvinyl alcohol, 1: 10 of volume ratio of oil to water, and 300 W of ultrasonic power. The optimized formulation of microspheres was as follows: the mass concentration of sodium alginate (NaALG) was 15 g / L ~ (-1) Span-80, the mass ratio of Ca CO3 to Na ALG was 1: 3, and the volume ratio of oil phase to water phase was 1: 5. The encapsulation efficiency, drug loading and average particle size of TAX-NiMS prepared under these conditions were (84.33 卤1.11) and (1.12 卤0.15)% and (2.678 卤0.014) 渭 m.TAX-NiMS, respectively. Conclusion the preparation method of TAX-NiMS is stable and controllable, and the effect of sudden release is significantly reduced, which provides a way for the development of new dosage forms of TAX-NiMS.
【作者单位】: 河北科技大学化学与制药工程学院;
【基金】:河北省杰出青年科学基金项目(H2014208004)
【分类号】:R943
[Abstract]:Objective to prepare paclitaxel nanoparticles-microspheres system (taxol nanoparticals-in-microsphere system,TAX-NiMS) and investigate its release characteristics in vitro. Methods the paclitaxel nanoparticles (taxol nanoparticals,TAX-NPs) were prepared by emulsifying solvent volatilization with polylactic acid-glycolic acid copolymer (poly (lactic-co-glycolic acid) as the carrier. The encapsulation efficiency, drug loading and particle size were used to optimize the formulation. The microspheres coated with TAX-NPs were prepared using calcium alginate as encapsulation material by internal emulsifying gel method. The surface and internal morphology of TAX-NiMS were observed by SEM and TEM, and its particle size and release characteristics in vitro were measured. Results the optimized formulation was 100 g / L ~ (-1), 10 g / L ~ (-1) of polyvinyl alcohol, 1: 10 of volume ratio of oil to water, and 300 W of ultrasonic power. The optimized formulation of microspheres was as follows: the mass concentration of sodium alginate (NaALG) was 15 g / L ~ (-1) Span-80, the mass ratio of Ca CO3 to Na ALG was 1: 3, and the volume ratio of oil phase to water phase was 1: 5. The encapsulation efficiency, drug loading and average particle size of TAX-NiMS prepared under these conditions were (84.33 卤1.11) and (1.12 卤0.15)% and (2.678 卤0.014) 渭 m.TAX-NiMS, respectively. Conclusion the preparation method of TAX-NiMS is stable and controllable, and the effect of sudden release is significantly reduced, which provides a way for the development of new dosage forms of TAX-NiMS.
【作者单位】: 河北科技大学化学与制药工程学院;
【基金】:河北省杰出青年科学基金项目(H2014208004)
【分类号】:R943
【参考文献】
相关期刊论文 前8条
1 陈孟夏;尹登科;梁杰;李珊珊;彭代银;;紫杉醇新剂型的研究进展[J];安徽医药;2014年04期
2 高萍;张啸;邹梅娟;韩佳容;安跃;程刚;;瑞舒伐他汀钙肠溶缓释微球的制备及影响因素考察[J];沈阳药科大学学报;2012年09期
3 刘韵;陈奋;尹飞;董江南;杨星钢;潘卫三;;美洛昔康纳米脂质载体的制备及表征[J];沈阳药科大学学报;2013年02期
4 刘芳;王淑君;;多西他赛纳米乳注射液的制备与质量控制[J];沈阳药科大学学报;2013年07期
5 赵萌;蔡沙;屈方宁;方亚鹏;;内源乳化法制备海藻酸盐微胶囊的研究进展[J];食品工业科技;2013年22期
6 王寅洁;胡海洋;乔明曦;赵秀丽;李丹;陈大为;;白蛋白包覆纳米脂质载体的制备与评价[J];沈阳药科大学学报;2014年05期
7 吕维玲;胡晋红;朱全刚;李凤前;;氢溴酸东莨菪碱纳米粒-微球系统的研制[J];药学学报;2010年07期
8 王薇;许鑫;胡戴;匡长春;李欧;符旭东;;紫杉醇脂质体的制备及其表征[J];中国药业;2013年22期
【共引文献】
相关期刊论文 前8条
1 槐敏;王进;王U,
本文编号:2257202
本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2257202.html
最近更新
教材专著